X0306 5 2020-12-31 0 0 1 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001684087 Young Caroline 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203 1 0 0 0 Common Stock 2020-07-08 4 L 0 15 3.33 A 9183 D Common Stock 2020-07-09 4 L 0 15 3.27 A 9198 D Common Stock 2020-07-10 4 L 0 15 3.24 A 9213 D Common Stock 2020-07-13 4 L 0 15 3.23 A 9228 D Common Stock 2020-07-14 4 L 0 15 3.26 A 9243 D Common Stock 2020-07-15 4 L 0 15 3.31 A 9258 D Common Stock 2020-07-16 4 L 0 15 3.34 A 9273 D Common Stock 2020-07-17 4 L 0 15 3.33 A 9288 D Common Stock 2020-07-20 4 L 0 15 3.52 A 9303 D Common Stock 2020-07-21 4 L 0 15 3.29 A 9318 D Common Stock 2020-07-22 4 L 0 15 3.22 A 9333 D Common Stock 2020-07-23 4 L 0 15 3.31 A 9348 D Common Stock 2020-07-24 4 L 0 15 3.31 A 9363 D Common Stock 2020-07-27 4 L 0 15 3.28 A 9378 D Common Stock 2020-07-28 4 L 0 15 3.26 A 9393 D Common Stock 2020-07-29 4 L 0 15 3.21 A 9408 D Common Stock 2020-07-30 4 L 0 15 3.22 A 8423 D Common Stock 2020-07-31 4 L 0 15 3.36 A 9438 D Common Stock 2020-08-03 4 L 0 15 3.43 A 9453 D Common Stock 2020-08-04 4 L 0 15 3.41 A 9468 D Common Stock 2020-08-05 4 L 0 15 3.44 A 9483 D Common Stock 2020-08-06 4 L 0 15 3.41 A 9498 D Common Stock 2020-08-07 4 L 0 15 3.43 A 9513 D Common Stock 2020-08-10 4 L 0 15 3.43 A 9528 D Common Stock 2020-08-11 4 L 0 15 3.43 A 9543 D Common Stock 2020-08-12 4 L 0 15 3.48 A 9558 D Common Stock 2020-08-13 4 L 0 15 3.48 A 9573 D Common Stock 2020-08-14 4 L 0 15 3.41 A 9588 D Common Stock 2020-08-17 4 L 0 15 3.35 A 9603 D Common Stock 2020-08-18 4 L 0 15 3.43 A 9618 D The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Filing 3 of 6 Caroline Young by /s/ Michael Bonner as attorney-in-fact 2021-02-05